Topiramate: A Viewpoint by Nathan Watemberg, MD

ISSN： 1172-7047

Source： CNS Drugs, Vol.17, Iss.13, 2003-01, pp. : 993-994

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Enoxaparin: A Viewpoint by Greg Elliott, M.D.

By Elliott G.

American Journal of Cardiovascular Drugs, Vol. 1, Iss. 6, 2001-06 ,pp. : 483-483

Adis International

Access to resources Recommend Favorite

Will China Democratize? by Andrew J. Nathan, Larry Diamond and Marc F. Plattner (eds). Baltimore, MD: Johns Hopkins University Press, 2013. 311pp., £19.50, ISBN 9781421412436

POLITICAL STUDIES REVIEW, Vol. 13, Iss. 3, 2015-08 ,pp. : 462-462

John Wiley & Sons Inc

Access to resources Recommend Favorite

Topiramate's the tipple

Inpharma, Vol. 1, Iss. 1388, 2003-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Topiramate: Aphasia: case report

Reactions Weekly, Vol. 1, Iss. 1148, 2007-01 ,pp. : 32-32

Adis International

Access to resources Recommend Favorite

Topiramate: Glaucoma: case report

Reactions Weekly, Vol. 1, Iss. 1096, 2006-01 ,pp. : 25-25

Adis International

Access to resources Recommend Favorite